ABSTRACT
Background: Hemangiomas are the commonest benign tumors of infancy and early childhood. Their natural course includes rapid progression during first year of life followed by regression. They can produce local and systemic complications and produce anxiety of the parents, thus necessitating therapeutic intervention. Various modalities of treatment are available for the treatment of hemangiomas. In this study we evaluated the effects of intralesional steroid therapy of hemangiomas
Methods: This study was conducted in the Department of Pediatric Surgery, Services Hospital, Lahore from March 2003 to April 2004. Fifty patients of capillary, cavernous or mixed types of hemangiomas were included in this study. Injection Triamcinolon was given intralesionally in dosage of 10 mg per square centimeter of the surface area of hemangioma but not exceeding the maximum dose of 5mg/kg. Each patient was followed up at three weeks interval
Results: it was found that this form of therapy is effective, easy to perform, cost effective and have minimal side effects
Conclusion. The intralesional steroid for hemangiomas is effective treatment with negligible side effects